Home | Back to newsletter main page
| |
 |
|
January 14, 2013 |
|
ANNOUNCEMENTSBing-Cheng Wang Honored with Professorship
Cheng-Kui Qu Lab Establishes a Crucial Role of PTPMT1 in the Metabolic Regulation of HSC Function
Strong Cancer-related Funding Week for Anant Madabhushi and Team
In addition, two people under the mentorship of Dr. Madabhushi also received funding news. Dr. Mirabela Rusu has been awarded a two-year DOD post-doctoral fellowship grant, Identifying MRI markers for viable, post-radiation prostate tumors in men undergoing radiation therapy followed by prostatectomy, and Dr. Satish Viswanath has been recommended for funding (contingent on fund availability) for a two-year DOD post-doctoral fellowship grant, Computerized Fusion of Elastography and Multiparametric Magnetic Resonance Imagery for Improved Prostate Cancer Diagnosis and Prognosis . Intersections: SOURCE Poster Award WinnersCongratulations to the following students mentored by Cancer Center members, who received awards at the December 2012 SOURCE Intersections Poster Competition:
Now in its ninth year, Intersections: SOURCE Symposium and Poster Session is where CWRU undergraduates present their research and creative projects. FUNDING OPPORTUNITIES/AWARDSLimited Submission: NIH Shared Instrumentation Grant ProgramThe Shared Instrumentation Grant (SIG) program provides a cost-effective mechanism for groups of NIH-supported investigators to obtain commercially-available equipment that costs more than $100,000. Instruments in this price range are typically too expensive to be obtained through a research project grant. The maximum SIG award is $600,000. Types of instruments supported include, but are not limited to, confocal and electron microscopes, biomedical imagers, mass spectrometers, DNA sequencers, biosensors, cell-sorters, X-ray diffraction systems, and Nuclear Magnetic Resonance (NMR) spectrometers among others. Each institution may submit ONE application per type of equipment. LOI Deadline: February 1 American Cancer Society IRG AwardsThe Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs. LOI Deadline: February 18 MARK YOUR CALENDARSTRCCC Annual Meeting: The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor ImmunityRegistration is open for the 16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC), The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity. Held February 20-22 at the Seven Springs Mountain Resort in Seven Springs, PA, this meeting will feature two symposiums focused on Tumor-mediated Immune Suppression and Vaccine and Cellular Therapy, with spotlight sessions on Imaging and Viral Vectors. The agenda will also include a poster session. Researchers, institutional officials, and students are invited to submit abstracts for poster presentations by February 4. NCI CANCER BULLETINJanuary 8, 2013News Multimedia In Depth Read Updates | EVENTS
January 14Cancer Center Research Chalk Talk January 15Radiation Oncology Grand Rounds Cancer Biology Invited Speaker Seminar Immunology Seminar Series Medicine Grand Rounds January 16Hematology and Oncology Division Research Conference Immunology Invited Speaker Seminar Series OnCore Clinical Trials Management System Training Classes Frontiers in Biological Sciences Lecture Series January 17Cancer Trainee Seminar National Center for Regenerative Medicine Seminar January 18Hematology/Oncology Fellows Conference/Curriculum Series Taussig Cancer Institute Grand Rounds Cancer Center Seminar Series Cancer Center Research in Progress
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSThe Role of Interferon in Metastasis and Resistance to DNA Damage in Prostate Cancer IMPACT: Improving Sickle Cell Patient Adherence Through Collaborative Teaching Breast Cancer Conference
ADDITIONAL UPCOMING SEMINARS & EVENTS16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRC3): The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity National GvHD Health Symposium |
|
|
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES |
|
|
2013 CTSC Annual Pilot Grant Funding |
Leukemia and Lymphoma Society Translational Research Program |
|
|
|
NIH BULLETIN – Notices and Funding OpportunitiesDissemination and Implementation Research in Health (R21)(PAR-13-054) Dissemination and Implementation Research in Health (R01)(PAR-13-055) Dissemination and Implementation Research in Health (R03)(PAR-13-056) Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)(PAR-13-080) Bridging the Gap Between Cancer Mechanism and Population Science (U01)(PAR-13-081) Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)(PAR-12-096) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216.844.8317 phone 216.844.7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|
Dr. Bing-Cheng Wang has been named the inaugural John and Josephine Wootton Professor in Research. Dr. Wang, Co-Leader of the Case CCC GU Malignancies Program, will be honored by the School of Medicine at a reception this week.
Recent work from the laboratory of Dr. Cheng-Kui Qu, 
The Center for Computational Imaging and Personalized Diagnostics (CCIPD) and a team led by Dr. Anant Madabhushi, Associate Professor and Director of the Center for Computational Imaging & Personalized Diagnostics, received updates on several important grants in the past week. Dr. Madabhushi will serve as Co-PI of a joint grant with Johns Hopkins, Active surveillance biomarkers for reclassification of Small Low Grade, Low Stage T1c Indolent Prostate Cancer Tumors, which was recommended for funding from the Department of Defense.